Powered by Google Google ÜbersetzerGoogle Übersetzer
Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Latest Press Releases
View all
TimeHeadline
18m agoCanadian Gold Resources Strengthens Board with Capital Markets Veteran Kenneth Chernin
18m agoWaraba Gold Signs Binding Agreement to Establish Joint Venture Relating to Tengrela South Exploration Permit Application in Cote d'Ivoire
18m agoSierra Madre Announces Shareholder Approval of Acquisition of Del Toro Silver Mine
18m agoFirst Quantum Minerals Reports First Quarter 2026 Results
18m agoDistrict Metals Announces $10 Million Private Placement Financing
Upstream Bio, Inc. logo

Upstream Bio, Inc.

About

Upstream Bio, Inc. (NASDAQ:UPB) — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 17 2026
Upstream Bio to Present New Data from Phase 2 VIBRANT Trial of Verekitug at the ATS 2026 International Conference
Mar 26 2026
Upstream Bio Highlights Phase 3 Development Strategy for Verekitug and Reports Fourth Quarter and Full Year 2025 Financial Results
Mar 1 2026
Upstream Bio Presents Additional Analyses from the Phase 2 VIBRANT Trial of Verekitug in Chronic Rhinosinusitis with Nasal Polyps at 2026 AAAAI Annual Meeting
Feb 26 2026
Upstream Bio to Present Additional Analyses from Phase 2 VIBRANT Trial in Chronic Rhinosinusitis with Nasal Polyps in Late-Breaking Session at AAAAI Annual Meeting 2026
Feb 25 2026
Upstream Bio to Participate in Upcoming March Investor Conferences

Financials

Revenue
$2.85 M
Market Cap
$567.06 M
EPS
-2.66

Community Chat

Ask AI

6ix6ixAIEvents